Clinical Trial: Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency

Study Status: Suspended
Recruit Status: Suspended
Study Type: Interventional

Official Title: Interest of Biofer ® Compound Used in Blédilait Follow on Milk and Growing Milk on Iron Status Evolution in Infant With Latent Iron Deficiency

Brief Summary: The primary purpose of the study is to demonstrate the superiority of Bledilait milk (Biofer® 2mg/100kcal) in comparison with ferrous sulphate supplemented milk (2 mg/100 kcal) in infants (6 to 12 months) with latent iron deficiency by measuring serum ferritin value after 2 months of consumption of studied milks.

Detailed Summary:
Sponsor: Bledina

Current Primary Outcome: Serum ferritin value measured after 2 months of studied milks consumption. [ Time Frame: 2 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: - Serum ferritin value - Serum ferritin evolution - CMV evolution - Red blood cells evolution - Common Infectious diseases - Antibiotic consumption [ Time Frame: baseline, baseline + 2 months, baseline + 4 months ]

Original Secondary Outcome: Same as current

Information By: Bledina

Dates:
Date Received: November 6, 2007
Date Started: November 2007
Date Completion: December 2008
Last Updated: November 14, 2008
Last Verified: November 2008